Develops drugs for various diseases.
Jun 2026Revenue $38.1B/yrExpenses $26.7B/yr
No trend
Figures by year
Is Amgen profitable?
Yes. In the 12 months to Jun 2026, revenue was $38.1B and expenses $26.7B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $36.8B | $27.7B | $9.08B |
| Dec 2024 | $33.4B | $26.2B | $7.26B |
| Dec 2023 | $28.2B | $20.3B | $7.90B |
| Dec 2022 | $26.3B | $16.8B | $9.57B |
| Dec 2021 | $26.0B | $18.3B | $7.64B |
| Dec 2020 | $25.4B | $16.3B | $9.14B |
| Dec 2019 | $23.4B | $13.7B | $9.67B |
| Dec 2018 | $23.7B | $13.5B | $10.3B |
| Dec 2017 | $22.8B | $12.9B | $9.97B |
| Dec 2016 | $23.0B | $13.2B | $9.79B |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.